Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system

Journal of the American Society of Nephrology

Volumn 17, Issue 9, 2006, Pages 2513-2520

  Kramer, Andrea ^a   Van Den Hoven, Mabel ^b,c   Rops, Angelique ^b,c   Wijnhoven, Tessa ^b,c   Van Den Heuvel, Lambert ^c   Lensen, Joost ^b   Van Kuppevelt, Toin ^b   Van Goor, Harry ^a   Van Der Vlag, Johan ^b,c   Navis, Gerjan ^a   Berden, Jo H M ^a,b,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; AGRIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIMETHYLTHIOUREA; DOXORUBICIN; HEPARAN SULFATE; HEPARANASE; HYDROXYL RADICAL; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; GLOMERULUS BASEMENT MEMBRANE; KIDNEY INJURY; MALE; NONHUMAN; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

EID: 33748033717     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006020184     Document Type: Article

References (43)

1. Raats CJ, Van Den Born J, Berden JH: Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria. Kidney Int 57: 385-400, 2000
2. Rosenzweig LJ, Kanwar YS: Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin. Lab Invest 47: 177-184, 1982
3. Kanwar YS, Linker A, Farquhar MG: Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 86: 688-693, 1980
4. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Berden JH: A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41: 115-123, 1992
5. Tamsma JT, van den Born J, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH, et al.: Expression of glomerular extracellular matrix components in human diabetic nephropathy: Decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37: 313-320, 1994
6. van den Born J, van den Heuvel LP, Bakker MA, Veerkamp JH, Assmann KJ, Weening JJ, Berden JH: Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 43: 454-463, 1993
7. Raats CJ, Bakker MA, van den Born J, Berden JH: Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem 272: 26734-26741, 1997
8. Raats CJ, Luca ME, Bakker MA, Van Der Wal A, Heeringa P, Van Goor H, Van Den Born J, De Heer E, Berden JH: Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis. J Am Soc Nephrol 10: 1689-1699, 1999
9. Wapstra FH, Navis GJ, van Goor H, van den Born J, Berden JH, de Jong PE, de Zeeuw D: ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established Adriamycin nephropathy. Exp Nephrol 9: 21-27, 2001
10. Parish CR, Freeman C, Hulett MD: Heparanase: A key enzyme involved in cell invasion. Biochim Biophys Acta 1471: M99-M108, 2001
11. Pikas DS, Li JP, Vlodavsky I, Lindahl U: Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 273: 18770-18777, 1998
12. Vlodavsky I, Friedmann Y: Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108: 341-347, 2001
13. Dempsey LA, Brunn GJ, Platt JL: Heparanase, a potential regulator of cell-matrix interactions. Trends Biochem Sci 25: 349-351, 2000
14. Maxhimer JB, Somenek M, Rao G, Pesce CE, Baldwin D Jr, Gattuso P, Schwartz MM, Lewis EJ, Prinz RA, Xu X: Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: A potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes 54: 2172-2178, 2005
15. Levidiotis V, Kanellis J, Ierino FL, Power DA: Increased expression of heparanase in puromycin aminonucleoside nephrosis. Kidney Int 60: 1287-1296, 2001
16. Levidiotis V, Freeman C, Punier M, Martinello P, Creese B, Ferro V, van der Vlag J, Berden JH, Parish CR, Power DA: A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis. J Am Soc Nephrol 15: 2882-2892, 2004
17. Levidiotis V, Freeman C, Tikellis C, Cooper ME, Power DA: Heparanase is involved in the pathogenesis of proteinuria as a result of glomerulonephritis. J Am Soc Nephrol 15: 68-78, 2004
18. Levidiotis V, Freeman C, Tikellis C, Cooper ME, Power DA: Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease. Nephrology (Carlton) 10: 167-173, 2005
19. Bertani T, Cutillo F, Zoja C, Broggini M, Remuzzi G: Tubulo-interstitial lesions mediate renal damage in Adriamycin glomerulopathy. Kidney Int 30: 488-496, 1986
20. De Boer E, Navis G, Tiebosch AT, De Jong PE, De Zeeuw D: Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in Adriamycin nephrotic rats. J Am Soc Nephrol 10: 2359-2366, 1999
21. Kramer AB, Ricardo SD, Kelly DJ, Waanders F, van Goor H, Navis G: Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis. J Pathol 207: 483-492, 2005
22. Kramer AB, Laverman GD, van Goor H, Navis G: Interindividual differences in anti-proteinuric response to ACEi in established Adriamycin nephrotic rats are predicted by pretreatment renal damage. J Pathol 201: 160-167, 2003
23. Raij L, Azar S, Keane W: Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 26: 137-143, 1984
24. Gambaro G, van der Woude FJ: Glycosaminoglycans: Use in treatment of diabetic nephropathy. J Am Soc Nephrol 11: 359-368, 2000
25. Wapsrra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D: Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established Adriamycin nephrosis. Clin Sci (Lond) 90: 393-401, 1996
26. Kim HJ, Ryu JH, Han SW, Park IK, Paik SS, Park MH, Paik DJ, Chung HS, Kim SW, Lee JU: Combined therapy of cilazapril and losartan has no additive effects in ameliorating Adriamycin-induced glomerulopathy. Nephron Physiol 97: 58-65, 2004
27. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345: 861-869, 2001
28. Gansevoort RT, de Zeeuw D, de Jong PE: Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease. Am J Kidney Dis 22: 202-206, 1993
29. Kohzuki M, Yasujima M, Kanazawa M, Yoshida K, Fu LP, Obara K, Saito T, Abe K: Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. J Hypertens 13: 97-103, 1995
30. Parving HH, Hommel E, Jensen BR, Hansen HP: Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int 60: 228-234, 2001
31. Brinkkoetter PT, Holtgrefe S, van der Woude FJ, Yard BA: Angiotensin II type 1-receptor mediated changes in heparan sulfate proteoglycans in human SV40 transformed podocytes. J Am Soc Nephrol 15: 33-40, 2004
32. Bos H, Laverman GD, Henning RH, Tiebosch AT, de Jong PE, de Zeeuw D, Navis G: Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated Adriamycin nephrotic rats. J Renin Angiotensin Aldosterone Syst 4: 106-112, 2003
33. Adler S, Huang H: Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 287: F907-F913, 2004
34. Campese VM, Shaohua Y, Huiquin Z: Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 46: 533-539, 2005
35. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC: Increased oxidative stress in experimental renovascular hypertension. Hypertension 37: 541-546, 2001
36. van Timmeren MM, Bakker SJ, Vaidya VS, Bailly V, Schuurs TA, Damman J, Stegeman CA, Bonventre JV, van Goor H: Tubular kidney injury molecule-1 in protein-overload nephropathy. Am J Physiol Renal Physiol 291: F456-F464, 2006
37. Feliers D, Gorin Y, Ghosh-Choudhury G, Abboud HE, Kasinath BS: Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species. Am J Physiol Renal Physiol 290: F927-F936, 2006
38. Hornig B, Landmesser U, Kohler C, Ahlersmann D, Spiekermann S, Christoph A, Tatge H, Drexler H: Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: Role of superoxide dismutase. Circulation 103: 799-805, 2001
39. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS: A mouse model of angiotensin II slow pressor response: Role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002
40. Ritz E, Haxsen V: Angiotensin II and oxidative stress: An unholy alliance. J Am Soc Nephrol 14: 2985-2987, 2003
41. van den Born J, Gunnarsson K, Bakker MA, Kjellen L, Kusche-Gullberg M, Maccarana M, Berden JH, Lindahl U: Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 270: 31303-31309, 1995
42. Raats CJ, Bakker MA, Hoch W, Tamboer WP, Groffen AJ, van den Heuvel LP, Berden JH, van den Born J: Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies. J Biol Chem 273: 17832-17838, 1998
43. Deen PM, Croes H, van Aubel RA, Ginsel LA, van Os CH: Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest 95: 2291-2296, 1995